Alkermes plc (Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences.

Stifel 2026 Healthcare Conference
Date/Time: Fireside chat on Tuesday, Nov. 10, 2026 at 10:40 a.m. ET (3:40 p.m. GMT)

Jefferies Global Healthcare Conference in London
Date/Time: Fireside chat on Wednesday, Nov. 18, 2026 at 11:30 a.m. ET (4:30 p.m. GMT)

The live webcasts may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc
Alkermes plc (Nasdaq: ALKS), a mid-cap growth and value equity, is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy. Alkermes has established a leadership position in orexin biology and is advancing a portfolio of investigational orexin 2 receptor agonists for narcolepsy, idiopathic hypersomnia and other psychiatric and neurological disorders, including attention-deficit hyperactivity disorder (ADHD), major depressive disorder (MDD) and fatigue associated with multiple sclerosis and Parkinson’s disease. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261103732068/en/

Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402

Tags

More Like This

Alkermes to Participate in Two Upcoming Investor Conferences

Alkermes to Participate in Two Upcoming Investor Conferences

Alkermes to Participate in Two Upcoming Investor Conferences

Alkermes to Participate in Two Upcoming Investor Conferences

Alkermes to Participate in Upcoming Investor Conferences

Alkermes to Participate in Two Upcoming Investor Conferences

Alkermes to Present at the TD Cowen 46th Annual Health Care Conference

Alkermes to Present at the Stifel 2026 Virtual CNS Forum